Kolexia
Lacut Karine
Endocrinologie
Hôpital Cavale Blanche
Brest, France
138 Activités
0 Followers

Scientifique
Digital
Production scientifique
Activités par an
Expertise
Sujets de recherche
{{person.topmesh1.name}} Thromboembolisme veineux Thromboembolie Embolie pulmonaire Hémorragie Embolie Thrombose veineuse Thrombose Obésité Accident vasculaire cérébral

Industries

A+A
6 collaboration(s)
Dernière en 2020
Bayer
3 collaboration(s)
Dernière en 2020
BMS
2 collaboration(s)
Dernière en 2021
GSK
2 collaboration(s)
Dernière en 2020

Dernières activités

SACHA: Major Bleeding Risk Associated With Antithrombotics : The SACHA (Surveillance Des Accidents Hémorragiques Graves Sous Antithrombotiques) Study
Essai Clinique (CHU Rennes)   15 novembre 2023
Pulmonary embolism diagnostic strategies in patients with COPD exacerbation: Post-hoc analysis of the PEP trial.
Thrombosis research   28 septembre 2023
Enoxaparin versus Placebo to Prevent Symptomatic Venous Thromboembolism in Hospitalized Older Adult Medical Patients.
NEJM evidence   27 juin 2023
Management of epistaxis associated with oral antithrombotic drugs in emergency department and impact on prescription thereafter.
Clinical otolaryngology : official journal of ENT-UK ; official journal of Netherlands Society for Oto-Rhino-Laryngology & Cervico-Facial Surgery   28 février 2023
Transferability of Published Population Pharmacokinetic Models for Apixaban and Rivaroxaban to Subjects with Obesity Treated for Venous Thromboembolism: A Systematic Review and External Evaluations.
Pharmaceutics   16 février 2023
Predictors of Recurrent Venous Thromboembolism or Arterial Thrombotic Events during and after Anticoagulation for a First Venous Thromboembolism.
Seminars in thrombosis and hemostasis   17 octobre 2022
Frequency and predictors for chronic thromboembolic pulmonary hypertension after a first unprovoked pulmonary embolism: Results from PADIS studies.
Journal of thrombosis and haemostasis : JTH   25 septembre 2022
Risk stratification for predicting recurrent venous thromboembolism after discontinuation of anticoagulation: a analysis of a French prospective multicentre study.
The European respiratory journal   22 septembre 2022
Risk Factors for Major Adverse Cardiovascular Events and Major Adverse Limb Events after Venous Thromboembolism: A Large Prospective Cohort Study.
Seminars in thrombosis and hemostasis   30 juin 2022
Risk Factors of Cardiovascular Death after Venous Thromboembolism: Results from a Prospective Cohort Study.
Thrombosis and haemostasis   18 juin 2022